We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ILA.AU

Price
0.17
Stock movement up
+0.01 (3.03%)
Company name
Island Pharmaceuticals Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
30.73M
Ent value
30.11M
Price/Sales
24.55
Price/Book
20.23
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
157.58%
3 year return
-6.80%
5 year return
-
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

ILA.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales24.55
Price to Book20.23
EV to Sales24.06

FINANCIALS

Per share

Loading...
Per share data
Current share count180.76M
EPS (TTM)-0.03
FCF per share (TTM)-0.04

Income statement

Loading...
Income statement data
Revenue (TTM)1.25M
Gross profit (TTM)-1.02M
Operating income (TTM)-5.40M
Net income (TTM)-3.44M
EPS (TTM)-0.03
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-81.58%
Operating margin (TTM)-431.52%
Profit margin (TTM)-275.00%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.66M
Net receivables890.67K
Total current assets2.56M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.56M
Accounts payable311.81K
Short/Current long term debt421.97K
Total current liabilities1.05M
Total liabilities1.05M
Shareholder's equity1.52M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-3.84M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-3.84M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-226.61%
Return on Assets-134.21%
Return on Invested Capital-177.34%
Cash Return on Invested Capital-198.09%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.16
Daily high0.17
Daily low0.15
Daily Volume27K
All-time high0.47
1y analyst estimate0.16
Beta0.05
EPS (TTM)-0.03
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ILA.AUS&P500
Current price drop from All-time high-63.83%-17.56%
Highest price drop-88.72%-56.47%
Date of highest drop1 May 20249 Mar 2009
Avg drop from high-64.72%-11.07%
Avg time to new high252 days12 days
Max time to new high1000 days1805 days
COMPANY DETAILS
ILA.AU (Island Pharmaceuticals Ltd) company logo
Marketcap
30.73M
Marketcap category
Small-cap
Description
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a collaboration agreement with Monash University and National Cancer Institute IND. It also has a cooperative research and development agreement with the U.S. Army, Island in preparation for its Phase 2a/b clinical study for ISLA-101. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found